References
- Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345: 1533–1536
- Franco E. Epidemiology of anogenital warts and cancer. Obstetric and Gynecologic Clinics of North America 1996; 23: 597–623
- Guido R. Guidelines for screening and treatment of cervical disease in the adolescent. Journal of Pediatric and Adolescent Gynecology 2004; 17: 303–311
- Moscicki A B, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. Journal of Pediatrics 1998; 132: 277–284
- Moscicki A B, Shiboski S, Hills N K, Powell K J, Jay N, Hanson E N, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678–1683
- Nash J, Burke T, Hoskins W. Biologic course of cervical human papillomavirus infection. Obstetrics and Gynecology 1987; 69: 160–162
- Syrjanen K, Kataja V, Yliskoski M. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstetrics and Gynecology 1992; 79: 675–682
- Van Belle G, Fischer L D, Heagerty P J, Lumley T S. Biostatistics: A methodology for the health sciences2nd ed. Wiley, New Jersey 2004
- Walboomers J M, Jacobs M V, Manos M M, Bosch F X, Kummer J A, Shah K V, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 1999; 189: 12–19
- Wright J D, Davila R M, Pinto K R, Merritt D F, Gibb R K, Rader J S, et al. Cervical dysplasia in adolescents. Obstetrics and Gynecology 2005; 106: 115–120